Übersicht über die in der EU zugelassenen COVID-19-Impfstoffe – von der Technologie über die klinische Prüfung zur Zulassung

Currently (as of July 2022), six different COVID-19 vaccines are licensed in the EU. These include two mRNA-based vaccines (BNT162b2, Comirnaty® and mRNA-1273, Spikevax®), two adenoviral vector-based vaccines (AZD1222, Vaxzevria® and Ad26.COV2.S, Jcovden®), the subunit vaccine Nuvaxovid® (NVX-CoV237...

Descripción completa

Detalles Bibliográficos
Autor principal: Hildt, Eberhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Leitthema
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579648/
https://www.ncbi.nlm.nih.gov/pubmed/36257986
http://dx.doi.org/10.1007/s00103-022-03600-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579648/
https://www.ncbi.nlm.nih.gov/pubmed/36257986
http://dx.doi.org/10.1007/s00103-022-03600-4

Ejemplares similares